Original article
Analysis of chromosomal abnormalities in human sperm after chemotherapy by karyotyping and fluorescence in situ hybridization (FISH)

https://doi.org/10.1016/0165-4608(94)00162-5Get rights and content

Abstract

The frequency of numerical and structural chromosomal abnormalities was studied in the sperm of a lymphoma patient 3 years after MACOP-B chemotherapy (CT). Sperm karyotyping was performed by fusion of human sperm with hamster oocytes and analysis of 193 Q-banded sperm chromosomes. Multicolor fluorescence in situ hybridization (FISH) was performed on 10,228 sperm for analysis of disomy frequencies for chromosomes 1 and 12 and on 10,664 sperm for chromosomes X and Y. Sperm karyotyping demonstrated numerical abnormalities in 7.3% of the spreads, 6.7% hypohaploid and 0.5% hyperhaploid, giving a conservative estimate of aneuploidy of 1%. Structural chromosomal abnormalities were present in 7.3% of the karyotypes and 0.5% had both numerical and structural abnormalities. Results of FISH analyses yielded disomy frequencies of 0.10%, 0.11%, 0.04%, 0.05%, and 0.18% for chromosomes 1, 12, X, Y, and XY, respectively. The frequency of diploid sperm was 0.09%. The frequency of abnormalities was not significantly increased compared to control donors for any of the studies. Also, the frequencies of X- and Y-bearing sperm did not differ significantly from 50% in the sperm karyotyping or FISH studies.

References (11)

There are more references available in the full text version of this article.

Cited by (48)

  • Acute anejaculation, hypogonadism, and fertility preservation in the setting of neurosarcoidosis: case report and literature review

    2020, F and S Reports
    Citation Excerpt :

    Despite having normal semen parameters, men treated with methotrexate had increased sperm oxidative stress and DNA fragmentation compared with control subjects (54). Case reports by Martin et al. and Melnyk et al., however, found that in their patients who used low-dose and high-dose methotrexate, respectively, chromosomal ploidy and structural abnormalities did not differ significantly compared with normal patients (55, 56). Pregnancy outcomes for couples conceiving naturally after paternal methotrexate therapy are more encouraging (Table 2).

  • Impact of Hodgkin or non-Hodgkin lymphoma and their treatments on sperm aneuploidy: a prospective study by the French CECOS network

    2017, Fertility and Sterility
    Citation Excerpt :

    Several studies have investigated sperm aneuploidy following treatment of lymphoma. However, these studies included small series of lymphoma patients (from 1 to 12) and used different methods, such as sperm karyotyping (29, 31, 34) or FISH (30–33, 35, 36), whereas one study used single sperm array comparative genomic hybridization (46). Moreover, these were retrospective or case report studies, with the exception of one prospective study (35).

  • Cisplatin disrupts mammalian spermatogenesis, but does not affect recombination or chromosome segregation

    2004, Mutation Research - Genetic Toxicology and Environmental Mutagenesis
View all citing articles on Scopus

This research was supported by the Medical Research Council of Canada, the Alberta Heritage Fund for Medical Research, and the Alberta Children's Hospital Research Foundation.

1

The authors are grateful for the cooperation of the cancer patient who made this study possible. The expert technical assistance of Leona Barclay, Kathy Hildebrand, and Evelyn Ko, and the secretarial skills of Debbie Bell, are grately acknowledged.

View full text